| Characterization of nuclear import of the domain-specific androgen receptor in association with the importin α/β and Ran-guanosine 5′-triphosphate systems N Kaku, K Matsuda, A Tsujimura, M Kawata Endocrinology 149 (8), 3960-3969, 2008 | 76 | 2008 |
| Application of Raman spectroscopy for visualizing biochemical changes during peripheral nerve injury in vitro and in vivo S Morisaki, C Ota, K Matsuda, N Kaku, H Fujiwara, R Oda, H Ishibashi, ... Journal of Biomedical Optics 18 (11), 116011-116011, 2013 | 40 | 2013 |
| Steroid receptor signalling in the brain–lessons learned from molecular imaging M Kawata, M Nishi, K Matsuda, H Sakamoto, N Kaku, M Masugi‐Tokita, ... Journal of neuroendocrinology 20 (6), 673-676, 2008 | 34 | 2008 |
| Detecting waning serological response with commercial immunoassays: 18-month longitudinal follow-up of anti-SARS-CoV-2 nucleocapsid antibodies Y Nakagama, Y Komase, N Kaku, Y Nitahara, E Tshibangu-Kabamba, ... Microbiology spectrum 10 (4), e00986-22, 2022 | 30 | 2022 |
| Intranuclear mobility of estrogen receptor α and progesterone receptors in association with nuclear matrix dynamics KI Matsuda, M Nishi, H Takaya, N Kaku, M Kawata Journal of cellular biochemistry 103 (1), 136-148, 2008 | 26 | 2008 |
| Antibody avidity maturation following recovery from infection or the booster vaccination grants breadth of SARS-CoV-2 neutralizing capacity Y Nakagama, K Candray, N Kaku, Y Komase, MV Rodriguez-Funes, ... The Journal of Infectious Diseases 227 (6), 780-787, 2023 | 25 | 2023 |
| A dual-antigen SARS-CoV-2 serological assay reflects antibody avidity Y Nakagama, Y Nitahara, N Kaku, E Tshibangu-Kabamba, Y Kido Journal of Clinical Microbiology 60 (2), e02262-21, 2022 | 25 | 2022 |
| High-resolution linear epitope mapping of the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 mRNA vaccine recipients Y Nitahara, Y Nakagama, N Kaku, K Candray, Y Michimuko, ... Microbiology Spectrum 9 (3), e00965-21, 2021 | 23 | 2021 |
| Serological testing reveals the hidden COVID-19 burden among health care workers experiencing a SARS-CoV-2 nosocomial outbreak Y Nakagama, Y Komase, K Candray, S Nakagama, F Sano, T Tsuchida, ... Microbiology Spectrum 9 (2), e01082-21, 2021 | 14 | 2021 |
| Kinetics of anti-SARS-CoV-2 antibody titer in healthy adults up to 6 months after BNT162b2 vaccination measured by two immunoassays: A prospective cohort study in Japan T Matsuura, W Fukushima, Y Nakagama, Y Kido, T Kase, K Kondo, ... Vaccine 40 (38), 5631-5640, 2022 | 13 | 2022 |
| Malaria infection among adults residing in a highly endemic region from the Democratic Republic of the Congo NK Kayiba, Y Nitahara, E Tshibangu-Kabamba, DK Mbuyi, ... Malaria Journal 23 (1), 82, 2024 | 7 | 2024 |
| Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study K Nakashima, M Ishida, H Matsui, C Yoshida, T Nagai, M Shiraga, ... Human Vaccines & Immunotherapeutics 18 (6), 2140549, 2022 | 6 | 2022 |
| High-resolution linear epitope mapping of the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 mRNA vaccine recipients. Microbiol Spectr. 2021; 9 (3): e0096521 … Y Nitahara, Y Nakagama, N Kaku, K Candray, Y Michimuko, ... Spectrum, 00965-21, 0 | 5 | |
| The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review NK Kayiba, E Tshibangu-Kabamba, A Rosas-Aguirre, N Kaku, ... Tropical Medicine and Health 51 (1), 64, 2023 | 4 | 2023 |
| Longitudinal ventilatory ratio monitoring for COVID-19: its potential in predicting severity and assessing treatment response N Kaku, Y Nakagama, M Shirano, S Shinomiya, K Shimazu, K Yamazaki, ... Critical Care 25, 1-3, 2021 | 4 | 2021 |
| Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America Y Nakagama, MV Rodriguez-Funes, R Dominguez, KS Candray-Medina, ... Clinical Microbiology and Infection 28 (11), 1508-1510, 2022 | 3 | 2022 |
| Usefulness of seasonal malaria chemoprevention in the Sahel NK Kalenda, E Tshibangu-Kabamba, Y Nakagama, N Kaku, A Kaneko, ... The Lancet Infectious Diseases 23 (3), 269-270, 2023 | 2 | 2023 |
| Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-naïve adults receiving the first four mRNA COVID-19 vaccine doses T Matsuura, W Fukushima, Y Nakagama, Y Kido, T Kase, K Kondo, ... Scientific Reports 14 (1), 7217, 2024 | 1 | 2024 |
| Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response S Nakagama, Y Nakagama, Y Komase, M Kudo, T Imai, ... Frontiers in Immunology 14, 1087473, 2023 | 1 | 2023 |
| The impact of prior COVID-19 on vaccine response and the resultant hybrid immunity are age-dependent S Nakagama, Y Nakagama, Y Komase, M Kudo, T Imai, Y Nitahara, ... MedRxiv, 2022.09. 19.22280079, 2022 | 1 | 2022 |
